Intellipharmaceutics International Inc. (IPCI)

[fabius]

I think (but it is just my idea) that they already have a pre-agreement for the oldest pending ANDAs, which are by the way, potentially much more lucrative than keppra.

if not, that would be a mistake, according to me.

I was really surprised about the keppra approval being treated as an issue ...ok, it's really a small market drug, but they need cash like hell, so I would have expected them to address a partnership right away.

I also believe that they cannot afford to realize themselves one og the drug, unless they secure a partnership granted a big bunch of cash.

Now it's the time where Della Penna should demonstrate something